| 期刊論文1. | Levey, A. S.、Coresh, J.、Balk, E.、Kausz, A. T.、Levin, A.、Steffes, M. W.、Eknoyan, G.(2003)。National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification。Annals of Internal Medicine,139(2),137-147。 | 2. | Chobanian, A. V.、Bakris, G. L.、Black, H. R.、Cushman, W. C.、Green, L. A.、Izzo, J. J.、Oparil, S.(2003)。The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure。JAMA,289(19),2560-2572。 | 3. | National Kidney Foundation(2002)。K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification。American Journal of Kidney Diseases,39(2),1-266。 | 4. | Hsu, C. C.、Hwang, S. J.、Wen, C. P.、Chang, H. Y.、Chen, T.、Shiu, R. S.、Yang, W. C.(2006)。High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative Survey。American Journal of Kidney Diseases,48(5),727-738。 | 5. | Wen, C. P.、Cheng, T. Y.、Tsai, M. K.、Chang, Y. C.、Chan, H. T.、Tsai, S. P.、Wen, S. F.、Chiang, P. H.、Hsu, C. C.、Sung, P. K.、Hsu, Y. H.(2008)。All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462,293 adults in Taiwan。The Lancet,371(9631),2173-2182。 | 6. | 楊芝青(2007)。慢性腎臟病危險因子的探討。北市醫學雜誌,4,880-9。 延伸查詢 | 7. | 楊芝青、陳維昭、陳再晉(2007)。我國慢性腎臟病防治工作回顧。血液淨化雜誌,12,49-56。 延伸查詢 | 8. | Kuo HW、Tsai SS、Tiao MM、Yang CY(2007)。Epidemiological features of CKD in Taiwan。Am J Kidney Dis,49,46-55。 | 9. | Coresh J, Byrd-Holt D, Astor BC, et al.(2005)。Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000。J Am Soc Nephrol,16,180-8。 | 10. | Coresh, J.、Astor, B. C.、Greene, T.、Eknoyan, G.、Levey, A. S.(2003)。Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey。American journal of kidney diseases,41(1),1-12。 | 11. | Brown WW, Peter RM, Ohmit SE, et al.(2003)。Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP)。Am J Kidney Dis,42,22-35。 | 12. | Chadban SJ, Briganti EM, Kerr PG, et al.(2003)。Prevalence of kidney damage in Australian adults: the AusDiab kidney study。J Am Soc Nephrol,14,S131-8。 | 13. | Chen J, Wildman RP, Gu D, et al.(2005)。Prevalence of decreased kidney function in Chinese adults aged 35-74 years。Kidney Int,68,2837-45。 | 14. | Zhang L, Zhang P, Wang F, et al.(2008)。Prevalence and factors associated with CKD: a population study from Beijing。Am J Kidney Dis,51,373-84。 | 15. | Becker MA, Jolly M.(2006)。Hyperuricemia and associated diseases。Rheum Dis Clin North Am,32,275-93。 | 16. | Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR.(2003)。Screening for proteinuria in US adults: a cost-effectiveness analysis。JAMA,290,3101-14。 | 17. | Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y.(2003)。The effects of weight loss on renal function in patients with severe obesity。J Am Soc Nephrol,14,1480-6。 | 18. | de Zeeuw D, Ramjit D, Zhang Z, et al.(2006)。Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL。Kidney Int,69,1675-82。 | 19. | Eriksen BO, Ingebretsen OC.(2006)。The progression of chronic kidney disease : a 10-year population-based study of the effects of gender and age。Kidney Int,69,375-82。 | 20. | Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D.(2004)。Predictors of newonset kidney disease in a community-based population。JAMA,291,844-50。 | 21. | Freedman BI, Volkova NV, Satko SG, et al.(2005)。Population-based screening for family history of endstage renal disease among incident dialysis patients。Am J Nephrol,25,529-35。 | 22. | Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J.(2003)。Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland。J Am Soc Nephrol,14,2934-41。 | 23. | Iseki, K.、Iseki, C.、Ikemiya, Y.、Fukiyama, K.(1996)。Risk of developing end-stage renal disease in a cohort of mass screening。Kidney International,49(3),800-805。 | 24. | Keane WF, Zhang Z, Lyle PA, et al.(2006)。Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study。Clin J Am Soc Nephrol,1,761-7。 | 25. | McClellan WM, Langston RD, Presley R.(2004)。Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease。J Am Soc Nephrol,15,1912-9。 | 26. | Satko SG, Freedman BI.(2004)。The importance of family history on the development of renal disease。Curr Opin Nephrol Hypertens,13,337-41。 | 27. | Schaeffner ES, Kurth T, Curhan GC, et al.(2003)。Cholesterol and the risk of renal dysfunction in apparently healthy men。J Am Soc Nephrol,14,2084-91。 | 28. | Taal MW, Brenner BM.(2006)。Predicting initiation and progression of chronic kidney disease: developing renal risk scores。Kidney Int,70,1694-705。 | 29. | Tarver-Carr ME, Powe NR, Eberhardt MS.(2002)。Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors。J Am Soc Nephrol,13,2363-70。 | 30. | Wrone EM, Carnethon MR, Palaniappan L, Fortmann SP.(2003)。Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey。Am J Kidney Dis,41,580-7。 | 31. | Huang MC, Chen ME, Hung HC, et al.(2008)。Inadequate energy and excess protein intakes may be associated with worsening renal function in chronic kidney disease。J Ren Nutr,18,187-94。 | 32. | Ma YC, Zuo L, Chen JH, et al.(2006)。Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease。J Am Soc Nephrol,17,2937-44。 | 33. | KDOQI(2006)。KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for anemia in chronic kidney disease。Am J Kidney Dis,47,S11-145。 | 34. | Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP, Rosevear JW.(1972)。Effects of urea loading in patients with far-advanced renal failure。Mayo Clin Proc,47,21-9。 | 35. | Lindeman, R. D.、Tobin, J.、Shock, N. W.(1985)。Longitudinal studies on the rate of decline in renal function with age。J Am Geriatr Soc.,33,278-285。 | 36. | Butler R, Morris AD, Belch JJ, et al.(2000)。Allopurinal normalizes endothelial dysfunction in type 2 diabetics with mild hypertension。Hypertension,35,746-51。 | 37. | Sanchez- Lozada LG, Nakagawa T, Kang DH, et al.(2006)。Hormonal and cytokine effects of uric acid。Curr Opin Nephrol Hypertens,15,30-3。 | 38. | Sanchez- Lozada LG, Tapia E, Santamaria J, et al.(2005)。Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats。Kidney Int,67,237-47。 | 39. | Scheinman JI.(2003)。Sickle cell disease and the kidney。Semin Nephrol,23,66-76。 | 40. | Mohanram A, Zhang Z, Shahinfar S, et al.(2004)。Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy。Kidney Int,66,1131-8。 | 41. | Park SK, Kang SK.(1995)。Renal function and hemodynamic study in obese Zucker rats。Korean J Int Med,10,48-53。 | 42. | Amin R, Turner C, van Aken S, et al.(2005)。The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: the Oxford Regional Prospective Study。Kidney Int,68,1740-9。 | 43. | Sakharova OV, Taal MW, Brenner BM.(2001)。Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor。Curr Opin Nephrol Hypertens,10,727-38。 | 會議論文1. | Yang WC, Hwang SC, Ng YY, et al.(2005)。A huge burden of stage III-V chronic kidney disease in Taiwan: a national prevalence estimate from TW3H QC monitoring。Washington, DC。abstr 262。 | 研究報告1. | 楊五常(2007)。研製慢性腎臟病防治手冊計畫。台北。 延伸查詢 | 2. | 行政院衛生署(2004)。成人健康體位挑戰1824。台北。 延伸查詢 | 3. | 行政院衛生署國民健康局(2004)。高血壓防治手冊--高血壓偵測、控制與治療流程指引。台北。 延伸查詢 | 4. | 行政院衛生署國民健康局(2004)。糖尿病防治手冊(糖尿病預防、診斷與控制流程指引)。台北。 延伸查詢 | 5. | 行政院衛生署國民健康局(2004)。高血脂防治手冊--國人血脂異常診療及預防指引。台北。 延伸查詢 | 圖書1. | 行政院衛生署國民健康局(2007)。中老年身心社會生活狀況長期追蹤調查。臺北市:行政院衛生署。 延伸查詢 | 2. | Hochberg MC, Smolen JS, Weinblatt ME, Weisman MH.(2003)。Rheumatology。New York, NY。 | |
| |